Top Section/Ad
Top Section/Ad
Most recent
BNPP is rebuilding strength in advisory in France
I thought the grass would be greener in fintech land, but it’s patchy and dreary
Years of underperformance are behind it and the bank has launched a new growth plan
Equity market bodies try to pre-empt regulator's July consultation and consolidated tape decision
More articles/Ad
More articles/Ad
More articles
-
Alkem Laboratories, a drug manufacturer, has lodged its preliminary prospectus with India’s regulator for a listing that could raise some $200m. The trade will be led by two local and two international banks. -
India threw a lifeline to its state-owned banks last week by pledging to inject more capital into its ailing lenders. While the move gives the banks a short-term reprieve, their ability to tap equity capital markets remains hampered by some deep-seated issues, say market participants.
-
Second quarter numbers for the big French banks tell the tale of two divergent markets – equities, which has had a buoyant quarter on the back of volatility, especially in Asia, and fixed income, which has languished as credit markets caught fright.
-
Barclays' investment bank is putting up the numbers for a new chairman who seems more supportive of the strategy than the ousted Antony Jenkins, writes David Rothnie.
-
The departure of a key southeast Asia banker from a global firm has thrust the region back into the spotlight, with banks battening down the hatches in expectation of a prolonged slump. Recruiters foresee another purge in jobs before the year is out, writes John Loh.
-
Société Générale’s top tier equities trading businesses delivered for the French bank in the second quarter, delivering a 61% increase in revenues to €799m, nearly half of total markets revenue.
